Devi SenGupta

5.6k citations
47 papers · 1.2k · 1 hit paper · h-index 19

Impact in

  • Virology top 2%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

    • HIV/AIDS drug development and treatment 10
    • HIV/AIDS Research and Interventions 4
    • Tuberculosis Research and Epidemiology 4
    • COVID-19 Clinical Research Studies 4
    • HIV Research and Treatment 17

Devi SenGupta

43 papers receiving 1.2k citations

Devi SenGupta's Hit Papers

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial 2017 · 292 citations
2920+3+6Years since publication50100150200250

Peers

Devi SenGupta
Comparison fields: 5 of 84
  • Virology 318
  • Infectious Diseases 595
  • Emergency Medicine 189
  • Immunology 165
  • Epidemiology 174
Replace Jose L. Matud with:
Jose L. Matud United States
Randall Lanier United States
Michel P. de Baar Netherlands
Wim Trypsteen Belgium
Moraima Guadalupe United States
Suzane Bazner United States
Joshua C. Cyktor United States
Antonio Más Spain
Joseph M. Gibbons United Kingdom
Mohammad A. Khan United States
Devi SenGupta relative to Jose L. Matud United States Jose L. Matud's profile →
Citations per field
00.5×4.3×
Jose L. Matud · 1×
Citations per year

Countries citing papers authored by Devi SenGupta

Since Specialization
Citations

This map shows the geographic impact of Devi SenGupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devi SenGupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devi SenGupta more than expected).

Fields of papers citing papers by Devi SenGupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devi SenGupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devi SenGupta. The network helps show where Devi SenGupta may publish in the future.

Co-authors

The 25 scholars most cited alongside Devi SenGupta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Devi SenGupta Line = papers co-authored together Devi SenGupta links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Hit paper breakdown →
2017292
2 2015160
3 200471
4 201152
5 202051
6 201446
7 201842
8 201441
9 201941
10 201639
11 201736
12 201633
13
AIDS in India: recent trends in opportunistic infections.
199831
14 201130
15 201629
16 201724
17 201222
18 201821
19 201420
20 198118

About Devi SenGupta

Devi SenGupta is a scholar working on Infectious Diseases, Virology, Immunology, Molecular Biology and Epidemiology, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (10 papers), Immune Cell Function and Interaction (5 papers), Chromosomal and Genetic Variations (5 papers), T-cell and B-cell Immunology (4 papers), HIV/AIDS Research and Interventions (4 papers), Tuberculosis Research and Epidemiology (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Virology (318 citations), Infectious Diseases (595 citations), Emergency Medicine (189 citations), Immunology (165 citations) and Epidemiology (174 citations). Devi SenGupta has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Andrew Cheng, Douglas F. Nixon, Anton Pozniak, Joseph M. Custodio, Erin Quirk, Steven G. Deeks, Kirsten White, Edwin DeJesus, Jihad Slim and Will Garner. Their work appears in journals such as Open Forum Infectious Diseases, The Lancet HIV, Journal of Virology, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact